Drug Target Review

DECEMBER 29, 2023

Scientists in China have published their findings 1 regarding novel biomarkers, which they hope will benefit patients by identifying the disease at an earlier stage. Minjia Tan’s group from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Shichun Du’s group from Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, analysed urinary and exosome proteome profiling and discovered biomarkers for diabetic kidney disease (DKD).

Disease 126

Disease Science Hospitals Treatment 126

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 — A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives. GSK, maker of the branded inhaler Flovent, will make "an authorized.

119

119

SCIENMAG: Medicine & Health

DECEMBER 29, 2023

This study is led by Dr. Shuyang Yu (College of Biological Sciences, China Agricultural University), Dr. Jingyu Xu (The Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University) and Dr.

Science 75

Science 75

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- A popular infant lounger violates U.S. safety standards because it poses a fall hazard and suffocation risk to babies, the U.S. Consumer Product Safety Commission (CPSC) warns.Though a notice of violation has been issued to.

Production 105

Production 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Covalent Modifiers

DECEMBER 29, 2023

Tomoyoshi Imaizumi, Itsuro Shimada, Yoshiki Satake, Susumu Yamaki, Takanori Koike, Takahiro Nigawara, Osamu Kaneko, Yasushi Amano, Kenichi Mori, Yosuke Yamanaka, Ayako Nakayama, Yoshihiro Nishizono, Masashi Shimazaki, Takeyuki Nagashima, Kazuyuki Kuramoto, Bioorganic & Medicinal Chemistry , 2023 , 117581 [link] Although KRAS protein had been classified as an undruggable target, inhibitors of KRAS G12C mutant protein were recently reported to show clinical efficacy in solid tumors.

Treatment 89

Treatment Drugs 89

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 — A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.GSK, maker of the branded inhaler Flovent, will make "an authorized.

105

105

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- Researchers appear to have discovered a new weapon in the war on a particularly difficult foe.They have identified a previously unrecognized class of antibodies that seem to be capable of neutralizing multiple strains of.

Vaccine 98

Vaccine Research 98

Drug Patent Watch

DECEMBER 29, 2023

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are twenty-one patents protecting… The post New patent expiration for NOVO drug SAXENDA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- Folks who habitually add an extra sprinkle of salt to their meals are doing no favors for their kidneys, new research confirms.The finding held even after researchers accounted for other health issues, such as being.

Research 98

Research 98

Drug Patent Watch

DECEMBER 29, 2023

Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included in one NDA. It is available from two suppliers. There… The post New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- The Vietnam war was a traumatic event in American history, most especially for those who served.However, there’s a glimmer of good news from recent research: Suicide rates for Vietnam veterans over the past four decades.

Research 98

Research 98

Drug Patent Watch

DECEMBER 29, 2023

Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. It is available from two suppliers. There are… The post New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- Tiny, powerful magnetic balls sold exclusively online at Walmart as building blocks and stress relievers have been recalled for swallowing dangers, the U.S. Consumer Products Safety Commission (CPSC) said Thursday.In.

Production 98

Production 98

Drug Patent Watch

DECEMBER 29, 2023

Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are six… The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- Seniors with vision issues are at much higher risk for dangerous falls, new research confirms.Compared to seniors with good vision, the odds for a fall rose by 38% for seniors with glaucoma, 36% for those with cataracts and.

Research 98

Research 98

Perficient: Drug Development

DECEMBER 29, 2023

Hello Trailblazers, In this blog post, we will learn how to write an Apex Trigger for Custom Validations. Acceptance Criteria: Write an Apex Trigger to restrict the Payment until the Final Quote is “Approved”. To solve this, we have custom objects named Payment__c and Final_Quote__c in a lookup relationship with each other. It’s lookup field name as “Quote__c”.

59

59

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- A new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.The therapy -- developed at the University of Nebraska Medical Center (UNMC) -- relies on both the immune system to.

Therapies 97

Therapies Disease Research 97

Cytel

DECEMBER 29, 2023

What a year! Perspectives has explored a myriad of topics this year within clinical development — from adaptive trial design to advice on regulatory submission to clinical data best practices, and so much more — all written by our many expert authors.

Clinical Development 59

Clinical Development Trials 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Perficient: Drug Development

DECEMBER 29, 2023

This series is my Next.js study resume, and despite it’s keen to a vanilla Next.js, all the features are applicable with Sitecore SDK. It is similar to the guide I recently wrote about GraphQL and aims reducing the learning curve for those switching to it from other tech stack. Next.js is a React-based framework designed for developing web applications with functionality beyond SPA.

International 52

International 52

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 -- More patients could benefit from immunotherapy, a highly effective treatment for some cancers, new research suggests.Revising current testing guidelines so that a more sophisticated test could be used more often would.

Treatment 52

Treatment Research 52

Perficient: Drug Development

DECEMBER 29, 2023

This blog post was co-authored by: Carl Aridas In a recent blog post, Perficient’s Financial Services Risk and Regulatory Center of Excellence (CoE) highlighted the Federal Deposit Insurance Corporation (FDIC) plan to implement a “Robin Hood-like” deposit insurance premium on the nation’s largest banks to recapitalize the agency’s Deposit Insurance Fund.

Compliance 52

Compliance 52

Drugs.com

DECEMBER 29, 2023

FRIDAY, Dec. 29, 2023 — From alcohol use to social isolation, poor hearing and heart disease, researchers have identified more than a dozen non-genetic factors that up the risk of dementia for people under 65.Though about 370,000 new cases a year.

Disease 52

Disease Research 52

biobide

DECEMBER 29, 2023

The appeal of vaping and modern tobacco products among today's youth has attracted a lot of attention and poses a threat to Society’s health. As these products gain popularity, concerns about their potential impact on health and influence on behavioral alterations in young individuals have grown. Rigorous toxicity testing are therefore vital in safeguarding the well-being of anyone who uses vapes and other modern tobacco products.

Production 52

Production 52

Perficient: Drug Development

DECEMBER 29, 2023

Burp Suite is a comprehensive web application security testing tool that provides a range of features to help identify vulnerabilities in web applications. One of its most powerful tools is Sequencer, which allows testers to analyze the randomness and quality of tokens and other random values used in web applications. In this blog, I’ll walk you through the step-by-step process of using Sequencer in Burp Suite: Open Burp Suite and navigate to the “Proxy” tab.

52

52

Alta Sciences

DECEMBER 29, 2023

Webinar—Sinclair Nanopig™: The Next Generation Non-Rodent Model for (Bio)Pharmaceuticals Safety Assessment lperez Fri, 12/29/2023 - 17:58 Image Website_Webinar_Minipig Sinclair_with Scott.

Pharmaceuticals 40

Pharmaceuticals Research 40

Drug & Device Law

DECEMBER 29, 2023

Another year bites the dust. We have just about made it through 2023, and while we have compiled our annual top ten best prescription medical product liability litigation decisions, we have the same sense with these as we did with last week’s bottom ten – in 2023 the favorable (as well as unfavorable) results from our product liability sandbox were rather overshadowed by impactful decisions elsewhere Eligibility for our top (or bottom) ten lists requires that the decision: (1) involve a presc

Testimonials 105

Testimonials FDA Drugs Vaccine 105

Alta Sciences

DECEMBER 29, 2023

Webinar—Nonclinical AAV Gene Therapy Development–Key Considerations on Study Design, Laboratory Endpoints, and Regulatory Guidance lperez Fri, 12/29/2023 - 18:03 Image Website_Webinar_BioA Gene Therapy.

Laboratories 40

Laboratories Therapies Research 40

Alta Sciences

DECEMBER 29, 2023

Life Science Review: Altasciences—Eliminating Operational Silos to Accelerate and Streamline Early-Phase Drug Development aasimakopoulos Fri, 12/29/2023 - 14:48 Category News Weight 5

Drug Development 40

Drug Development Science Drugs 40

Alta Sciences

DECEMBER 29, 2023

PBSS—ADME/DMPK Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices lperez Fri, 12/29/2023 - 16:20 Image GettyImages-1075448458.

Small Molecule 40

Small Molecule 40

Alta Sciences

DECEMBER 29, 2023

Society for Birth Defects Research and Prevention 64th Annual Meeting lperez Fri, 12/29/2023 - 17:10 Image GettyImages-951973848.

Research 40

Research 40

Alta Sciences

DECEMBER 29, 2023

Northern California 2024 Spring Symposium lperez Fri, 12/29/2023 - 16:43 Image GettyImages-904795294_0.

40

40

Alta Sciences

DECEMBER 29, 2023

AAPS National Biotechnology Conference lperez Fri, 12/29/2023 - 16:13 Image GettyImages-904795294.

40

40

Alta Sciences

DECEMBER 29, 2023

SOT 63rd Annual Meeting and ToxExpo lperez Fri, 12/29/2023 - 16:29 Image GettyImages-168717029.

40

40